Press release
Graves Ophthalmopathy Market to Expand Significantly by 2034, States DelveInsight Report | Novartis, AdvanceCor, Apitope, Worg Pharma, AV7 Limited
The Key Graves Ophthalmopathy Companies in the market include - Immunovant Sciences GmbH, Horizon Pharma USA, Inc., Viridian Therapeutics, Inc., Tourmaline Bio, Inc., ACELYRIN Inc., Hoffmann-La Roche, Horizon Therapeutics USA, Inc., Lassen Therapeutics Inc., Novartis, Sling Therapeutics, Inc., Lassen Therapeutics, and others.The Graves Ophthalmopathy market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Graves Ophthalmopathy pipeline products will significantly revolutionize the Graves Ophthalmopathy market dynamics.
DelveInsight's "Graves Ophthalmopathy Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Graves Ophthalmopathy, historical and forecasted epidemiology as well as the Graves Ophthalmopathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Graves Ophthalmopathy market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2020 to 2034. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
To Know in detail about the Graves Ophthalmopathy market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Graves Ophthalmopathy Market Forecast [https://www.delveinsight.com/sample-request/graves-ophthalmopathy-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Graves Ophthalmopathy Market Report:
*
The Graves Ophthalmopathy market size was valued approximately USD 2600 million in 2023 and is anticipated to grow with a significant CAGR during the study period (2020-2034)
*
In September 2024, Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company dedicated to discovering and developing potential best-in-class treatments for serious and rare diseases, today announced promising topline results from the THRIVE phase 3 clinical trial of VRDN-001, now known as veligrotug. This intravenously administered anti-insulin-like growth factor-1 receptor (IGF-1R) antibody is being evaluated in patients with active thyroid eye disease (TED), an autoimmune disorder marked by inflammation, growth, and damage to the tissues surrounding and behind the eyes
*
In 2022, approximately 2,385,900 cases of Graves Ophthalmopathy were reported in the seven major markets (7MM), and it is anticipated that these figures will rise throughout the study period from 2020 to 2034.
*
In 2022, it was estimated that there were approximately 448,800 diagnosed prevalent cases of Graves Ophthalmopathy in the United States. It is projected that these cases will increase over the study period from 2020 to 2034.
*
In 2022, Germany had the highest number of diagnosed prevalent cases of Graves Ophthalmopathy patients among the EU4 and the UK, with around 105,900 cases. Conversely, Spain had the fewest cases, with approximately 59,200 cases in 2022.
*
In the United States, the number of diagnosed prevalent cases of Graves Ophthalmopathy was higher among females compared to males in 2022, with approximately 89,800 cases in males and around 359,000 cases in females.
*
Key Graves Ophthalmopathy Companies: Immunovant Sciences GmbH, Horizon Pharma USA, Inc., Viridian Therapeutics, Inc., Tourmaline Bio, Inc., ACELYRIN Inc., Hoffmann-La Roche, Horizon Therapeutics USA, Inc., Lassen Therapeutics Inc., Novartis, Sling Therapeutics, Inc., Lassen Therapeutics, and others
*
Key Graves Ophthalmopathy Therapies: Batoclimab (IMVT 1401), RVT-1401, Teprotumumab, VRDN-001 10 mg/kg Drug, TOUR006 - 20 MG, IBI311, lonigutamab, Satralizumab, TEPEZZA, LASN01, CFZ533, linsitinib, LASN01, and others
*
The Graves Ophthalmopathy epidemiology based on gender analyzed that the females are affected more as compared to males in the case of Graves Ophthalmopathy
Graves Ophthalmopathy Overview
Graves' ophthalmopathy, also known as thyroid eye disease or Graves' orbitopathy, is a condition characterized by inflammation and swelling of the tissues surrounding the eyes. It is commonly associated with Graves' disease, an autoimmune disorder that affects the thyroid gland, leading to hyperthyroidism (overactive thyroid).
Get a Free sample for the Graves Ophthalmopathy Market Report -
https://www.delveinsight.com/report-store/graves-ophthalmopathy-market [https://www.delveinsight.com/report-store/graves-ophthalmopathy-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Graves Ophthalmopathy Market
The dynamics of the Graves Ophthalmopathy market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2020-2034.
"The DAVIAD project successfully resulted in the manufacture GMP grade ATX-GD-59 and completion of pharmacodynamic and toxicology studies in order to progress the therapeutic vaccine into a Phase I/IIa clinical trial. In the clinical trial, the vaccine was proven to be safe and well tolerated."
Graves Ophthalmopathy Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Graves Ophthalmopathy Epidemiology Segmentation:
The Graves Ophthalmopathy market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
*
Prevalent Cases of Graves Ophthalmopathy in the 7MM
*
Diagnosed Prevalent Cases of Graves Ophthalmopathy in the 7MM
*
Gender-specific Diagnosed Prevalent Cases of Graves Ophthalmopathy in the 7MM
*
Moderate-to-severe Drug-treated Cases of Acute Graves Ophthalmopathy in the 7MM
*
Acute Diagnosed Prevalent Cases of Graves Ophthalmopathy in the 7MM
*
Diagnosed Prevalent Cases of Graves Ophthalmopathy by Chronicity in the 7MM
Download the report to understand which factors are driving Graves Ophthalmopathy epidemiology trends @ Graves Ophthalmopathy Epidemiological Insights [https://www.delveinsight.com/sample-request/graves-ophthalmopathy-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Graves Ophthalmopathy Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Graves Ophthalmopathy market or expected to get launched during the study period. The analysis covers Graves Ophthalmopathy market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Graves Ophthalmopathy Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Graves Ophthalmopathy Therapies and Key Companies
*
Batoclimab (IMVT 1401): Immunovant Sciences
*
RVT-1401: Immunovant Sciences GmbH
*
Teprotumumab: Horizon Pharma USA, Inc.
*
VRDN-001 10 mg/kg Drug: Viridian Therapeutics, Inc.
*
Batoclimab: Immunovant Sciences GmbH
*
TOUR006 - 20 MG: Tourmaline Bio, Inc.
*
IBI311: Innovent Biologics (Suzhou) Co. Ltd.
*
lonigutamab: ACELYRIN Inc.
*
Satralizumab: Hoffmann-La Roche
*
TEPEZZA: Horizon Therapeutics USA, Inc.
*
LASN01: Lassen Therapeutics Inc.
*
CFZ533: Novartis
*
linsitinib: Sling Therapeutics, Inc.
*
LASN01: Lassen Therapeutics
To know more about Graves Ophthalmopathy treatment, visit @ Graves Ophthalmopathy Medications [https://www.delveinsight.com/sample-request/graves-ophthalmopathy-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Graves Ophthalmopathy Market Strengths
*
The recent US FDA approval of Horizon's TEPEZZA has accelerated the research and development of GO.
*
Recent efforts to increase patient and clinician awareness of GO, with various awareness campaigns, are expected to increase early diagnosis and treatment of GO.
Graves Ophthalmopathy Market opportunities
*
Designing an effective molecule with an intended delivery mode that is matched to the intended target compartment is a necessary first step in ocular drug discovery programs.
*
Lack of availability of disease-modifying treatment for chronic patients, who have a significant impact on their emotional and social well-being.
Scope of the Graves Ophthalmopathy Market Report
*
Study Period: 2020-2034
*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
*
Key Graves Ophthalmopathy Companies: Novartis, AdvanceCor, Apitope, Worg Pharmaceuticals, AV7 Limited, and others
*
Key Graves Ophthalmopathy Therapies: Batoclimab (IMVT 1401), RVT-1401, Teprotumumab, VRDN-001 10 mg/kg Drug, TOUR006 - 20 MG, IBI311, lonigutamab, Satralizumab, TEPEZZA, LASN01, CFZ533, linsitinib, LASN01, and others
*
Graves Ophthalmopathy Therapeutic Assessment: Graves Ophthalmopathy current marketed and Graves Ophthalmopathy emerging therapies
*
Graves Ophthalmopathy Market Dynamics: Graves Ophthalmopathy market drivers and Graves Ophthalmopathy market barriers
*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
*
Graves Ophthalmopathy Unmet Needs, KOL's views, Analyst's views, Graves Ophthalmopathy Market Access and Reimbursement
Discover more about therapies set to grab major Graves Ophthalmopathy market share @ Graves Ophthalmopathy Treatment Landscape [https://www.delveinsight.com/sample-request/graves-ophthalmopathy-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Graves Ophthalmopathy Market Report Introduction
2. Executive Summary for Graves Ophthalmopathy
3. SWOT analysis of Graves Ophthalmopathy
4. Graves Ophthalmopathy Patient Share (%) Overview at a Glance
5. Graves Ophthalmopathy Market Overview at a Glance
6. Graves Ophthalmopathy Disease Background and Overview
7. Graves Ophthalmopathy Epidemiology and Patient Population
8. Country-Specific Patient Population of Graves Ophthalmopathy
9. Graves Ophthalmopathy Current Treatment and Medical Practices
10. Graves Ophthalmopathy Unmet Needs
11. Graves Ophthalmopathy Emerging Therapies
12. Graves Ophthalmopathy Market Outlook
13. Country-Wise Graves Ophthalmopathy Market Analysis (2020-2034)
14. Graves Ophthalmopathy Market Access and Reimbursement of Therapies
15. Graves Ophthalmopathy Market Drivers
16. Graves Ophthalmopathy Market Barriers
17. Graves Ophthalmopathy Appendix
18. Graves Ophthalmopathy Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=graves-ophthalmopathy-market-to-expand-significantly-by-2034-states-delveinsight-report-novartis-advancecor-apitope-worg-pharma-av7-limited]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Graves Ophthalmopathy Market to Expand Significantly by 2034, States DelveInsight Report | Novartis, AdvanceCor, Apitope, Worg Pharma, AV7 Limited here
News-ID: 3840152 • Views: …
More Releases from ABNewswire

FiscalExpat.com Launches as Premier International Tax Intelligence Platform
Wyoming-Based Digital Publication Aims to Become Definitive Authority on Cross-Border Taxation
Cheyenne, Wyoming - Sep 30, 2025 - International taxation has never been more complex, and reliable guidance has never been harder to find. FiscalExpat.com (https://fiscalexpat.com [https://fiscalexpat.com/]) launches today as a comprehensive digital resource dedicated to helping expatriates, remote workers, and international professionals navigate the intricate world of cross-border tax compliance.
The platform addresses a critical gap in the market: the lack…

New Jersey Dentist Dr. Lee of Inspo Dental in Red Bank Offers Free Dental Care f …
Red Bank, NJ - Sep 30, 2025 - Inspo Dental, a leading New Jersey dental office in Red Bank, is giving back to the community with a special event dedicated to local heroes. On Wednesday, November 19th, 2025, Inspo Dental will host "For the Brave, From the Heart" -a free day of dentistry in New Jersey [https://www.inspodental.com/] for first responders and veterans, including police officers, firefighters, EMS, corrections officers, dispatchers,…

Tampa Attorney Offers Free Seminar to Help Families Avoid the Chaos of Planning …
The Faulkner Firm today announced a free community seminar aimed at helping Tampa-area families secure their futures and avoid the emotional and financial burden of unplanned estates. Titled "Don't Leave a Mess. Leave a Legacy," the event is a direct response to the staggering statistic that nearly half of all American adults lack basic estate planning documents.
Hosted by firm founder and attorney Debbie Faulkner, the workshop will provide a compassionate,…

Confidencias del corazon by Carlos Mavila: A Poetic Tribute to Love, Memory, and …
At a time when poetry is regaining its voice as a space of intimacy and reflection, Latin American poet Carlos Mavila V. A. presents Confidencias del corazon , the second volume of his Alma Poetica series. Now available worldwide on Amazon [https://www.amazon.com/Confidencias-coraz%C3%B3n-Alma-po%C3%A9tica-Spanish-ebook/dp/B0FMPNBM89/?utm_source=chatgpt.com], this book gathers seventy-six poems written across decades, a lyrical mosaic that portrays love in its many transformations-from passion to silence, absence to reconciliation, illusion to maturity.
A Journey…
More Releases for Graves
Graves' Disease Market New Product Development & Latest Trends
Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overproduction of thyroid hormones, through antibodies that stimulate the thyroid gland. It is among the most common thyroid-related autoimmune conditions, disproportionately affecting women between 30-60 years of age. Beyond metabolic complications such as weight loss, heat intolerance, and palpitations, Graves' disease can cause thyroid eye disease (TED), which impairs vision and quality of life.
For decades, treatment has relied on antithyroid…
Graves Ophthalmopathy Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Graves Ophthalmopathy Pipeline Insight 2024" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Graves Ophthalmopathy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Graves Ophthalmopathy Research. Learn more about…
Search for graves and burials in Minsk
If you are looking for information about the location of the grave in Minsk or other regions of Belarus, the company https://verimby.com +375293887408 (Viber); +375447498518 (WhatsApp) offers professional assistance in this important matter. We specialize in finding burial sites, providing detailed data and providing support in restoring lost ties with the past, creating a family tree, even if you are in another country.
Why can the search for graves in Belarus…
Graves' Disease Treatment Market Size, Drugs, Companies 2034 | DelveInsight
Graves' Disease Treatment Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and increasing awareness of the condition. The pipeline for Graves' Disease Therapeutics includes promising candidates that aim to not only treat acute attacks but also prevent recurrence.
DelveInsight's "Graves' Disease Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of the Graves' Disease, historical and…
Japan Graves' disease Market Size & Growth Analysis Report, 2019-2025
Japan Graves' disease market is growing at a CAGR of around 4.7% during the forecast period. According to the WHO, around 10.1% of the country's population is suffering from diabetes, among which, the individuals suffering from type-1 diabetes are more prone to develop Grave's disease in the near future. According to IDF, around 2.2 per thousand children and adolescents aged 14 years and below are suffering from type-1 diabetes in…
Global Graves Disease Market Status and Outlook (2020-2025)
Global Info Research offers a latest published report on Graves Disease Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Graves Disease Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/reports/515950/graves-disease
Market…